The following are some key findings from the narrative review on the gut-brain connection, with a focus on its role in neurological and psychiatric disorders:

The gut microbiome is essential for normal brain development and function. Studies have shown that animals with disrupted gut microbiomes exhibit a variety of behavioral and cognitive impairments, including anxiety, depression, and impaired learning and memory. Table 1 describes the Key mechanisms of the Gut-Brain connection. The gut microbiome communicates with the CNS through a variety of mechanisms, including the vagus nerve, SCFAs, and other signaling molecules.

The vagus nerve is a major nerve that connects the gut to the brain. It transmits signals in both directions, allowing the gut and brain to communicate with each other. SCFAs are small molecules that are produced by the gut microbiome

and can cross the blood-brain barrier to interact with receptors in the brain. SCFAs have been shown to have a variety of beneficial effects on the CNS, including reducing inflammation, improving mood, and enhancing cognitive function. The gut-brain connection is thought to play a role in a variety of neurological and psychiatric disorders, including depression, anxiety, autism, Multiple sclerosis and Alzheimer’s disease. Research has shown that people with these disorders often have alterations in their gut microbiome. For example, people with depression have been shown to have lower levels of certain beneficial bacteria in their gut. These bacteria produce SCFAs, which have antidepressant effects [10] .

Vagus nerve stimulation: Gut microbiome acts as the conductor, influencing gene expression through its chemical messengers, the vagus nerve serves as a vital conductor’s baton in the gut-brain orchestra. Vagus nerve stimulation (VNS) is a promising therapeutic approach that involves sending electrical impulses directly to the nerve. This stimulation can mimic the natural activity of the vagus nerve, potentially influencing various aspects of gut health and brain function. Studies suggest that VNS may be beneficial for treating conditions like inflammatory bowel disease, irritable bowel syndrome, and even depression and anxiety. By directly influencing the vagus nerve, VNS can potentially modulate the gut-brain communication pathway, potentially restoring balance and alleviating symptoms. While research on VNS is still ongoing, its potential to act as a direct conductor in the gut-brain orchestra offers exciting possibilities for future treatments. It underscores the complex interplay between our gut microbes, our genes, and the intricate nervous system, highlighting the potential for targeted interventions to promote health and well-being [11] .

As shown in Table 2, the emerging therapeutic strategies targeting the gut-brain connection include probiotics, prebiotics, and faecal microbiota transplantation [12] . Probiotics are live microorganisms that are similar to the beneficial bacteria that are naturally found in the gut. Prebiotics are non-digestible fibers that feed the beneficial bacteria in the gut. Faecal microbiota transplantation (FMT) is a procedure in which faecal matter from a healthy donor is transplanted into the gut of a person with a diseased microbiome. Probiotics, prebiotics, and FMT have been shown to be effective in treating a variety of gastrointestinal disorders, and there is growing evidence that they may also be effective in treating neurological and psychiatric disorders [13] .

Research has shown that people with these following disorders often have alterations in their gut microbiome.

Depression is a common mental health disorder that is characterized by persistent feelings of sadness and loss of interest in normal activities. Research has shown that people with depression often have lower levels of certain beneficial bacteria in their gut. These bacteria produce SCFAs, which have antidepressant

effects. A study published in the Nature Communication found that mice with disrupted gut microbiomes were more likely to develop depressive-like behaviors. However, when the mice were given a probiotic supplement, their depressive-like behaviors were found to be reduced [14] . Another study published in the journal Translational Psychiatry found that people with depression had lower levels of certain beneficial bacteria in their gut than people without depression. The researchers also found that people with depression who took a probiotic supplement for few weeks showed significant improvements in their mood and depressive symptoms [15] .

Anxiety is another common mental health disorder that is characterized by excessive worry and fear. Research has shown that people with anxiety often have alterations in their gut microbiome. A study published in the journal Molecular Psychiatry found that mice with disrupted gut microbiomes were more likely to develop anxiety-like behaviors. However, when the mice were given a probiotic supplement, their anxiety-like behaviors were found to be reduced [16] .

Another study published by Xiong et al. in 2023 found that people with anxiety had lower levels of certain beneficial bacteria in their gut than people without anxiety. The researchers also found that people with anxiety who took a probiotic supplement for eight weeks showed significant reductions in their anxiety symptoms [17] .

Autism is a neurodevelopmental disorder that is characterized by deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, or activities. Research has shown that people with autism often have alterations in their gut microbiome. A study published in the journal Cell found that children with autism had lower levels of certain beneficial bacteria in their gut than children without autism. The researchers also found that children with autism who took a probiotic supplement showed significant improvements in their social communication and interaction skills [18] . Another study published by Sivamaruthi et al. found that people with autism had lower levels of certain beneficial bacteria in their gut than people without autism. The researchers also found that people with autism who took a probiotic supplement showed significant reductions in their repetitive behaviors and restricted interests [19] . It has been known that the consumption of probiotics confers several health benefits by positive amendment of gut microbiota. The influence of probiotic intervention in children with ASD has also been reported and it has been considered as an alternative and complementary therapeutic supplement for ASD.

Alzheimer’s disease is a neurodegenerative disorder that is characterized by progressive cognitive decline and memory loss. Research has shown that people with Alzheimer’s disease often have alterations in their gut microbiome. A study published by Chandra et al. found that mice with disrupted gut microbiomes were more likely to develop amyloid plaque and tau tangles, which are the hallmarks of Alzheimer’s disease. However, when the mice were given a probiotic supplement, the development of amyloid plaque and tau tangles was reduced [20] . As the body’s master regulator of inflammation, the gut microbiome (GMB) plays a critical role in the onset and course of disorders affecting both peripheral and central inflammation [21] . Comprehending the ways in which the GMB can impact the advancement of Alzheimer’s disease (AD) might unveil a significant therapeutic target capable of regulating several pathogenic pathways. Since early research showed that GMB change has a substantial impact on AD-related pathology and that GMB composition is considerably different in AD patients compared to healthy controls [22] .

PD is mainly characterized by both motor and non-motor disturbances. PD is primarily distinguished by abnormalities that are both motor and non-motor. The most common symptoms on the motor side are rigidity, resting tremor, and slowness of movement. Significant impairment is a result of non-motor factors such as autonomic dysfunction, mood deflection, depression, sensory alternations, sleep alternations, and cognitive problems. The build-up of α-synuclein in both the central and peripheral nerve systems is reflected in this broad clinical spectrum [23] . Most PD patients have symptoms related to their gastrointestinal tract (GI). Patients with Parkinson’s disease (PD) have been shown to exhibit a range of gastrointestinal symptoms, including dysphagia, constipation, nausea, changed bowel habits, and defecatory dysfunction [24] .

Multiple sclerosis (MS) is a complex autoimmune disease that predominantly affects young adults, causing damage to the central nervous system, specifically the brain and spinal cord. Emerging research has revealed the involvement of gut microbiota in the pathophysiology of MS, offering a fresh viewpoint on the gut-brain axis. Immunosuppressive drugs and disease-modifying treatments (DMTs) used in MS treatment may have an effect on the gut microbiota. Alterations in the composition of the gut microbiota have been associated with a number of therapies, such as fingolimod, dimethyl fumarate, interferon-beta, and glatiramer acetate [25] . Alemtuzumab induces systemic lymphocyte depletion, which has an effect on the gut flora [26] . Steroids may change the composition of the gut flora and are commonly used to manage relapses [27] . Among other symptomatic drugs, antidepressants and cannabis may affect the composition of the gut flora [28] .

These are just a few examples of the growing body of research on the gut-brain connection and its role in neurological and psychiatric disorders. More research is needed to fully understand the mechanisms underlying the gut-brain connection and to develop safe and effective therapies that target this pathway.

The research on the gut-brain connection is still in its early stages, but the findings to date are promising. More research is needed to fully understand the mechanisms underlying the gut-brain connection and to develop safe and effective therapies that target this pathway. One of the key challenges in researching the gut-brain connection is the complexity of the gut microbiome. The gut microbiome is a diverse community of trillions of microorganisms, and each individual has a unique microbiome fingerprint [29] . This makes it difficult to identify the specific bacteria that are involved in the gut-brain connection and their mechanisms of action.

Another challenge is the lack of standardized methods for measuring the gut-brain connection. There are a variety of different techniques that can be used to measure the gut microbiome and its activity, but these techniques are not always consistent. This makes it difficult to compare the results of different studies and to draw conclusions about the gut-brain connection [30] .

Despite these challenges, the research on the gut-brain connection is rapidly advancing. New technologies are being developed to study the gut microbiome in more detail, and new methods are being developed to measure the gut-brain connection. Emerging technologies including engineered organoids derived from human stem cells, high-throughput culturing, and microfluidics assays allowing for the introduction of novel approaches will improve the efficiency and quality of microbiome research [31] .

In order to improve our understanding of complex microbial communities, their internal relationships, and their interactions with hosts and environments, microbiome bioinformatics aims to provide computational methodologies and procedures that complement experimental approaches. With a focus on processing high throughput sequencing of variable regions of bacterial 16S ribosomal genes and an emphasis on exploratory data analysis and taxonomic composition visualisation, current bioinformatic practise is largely encapsulated in the software platforms Mothur [32] and QIIME [33] . Through complementing taxonomic diversity analysis, whole genome shotgun sequencing (WGS), and metatranscriptomic sequencing, emerging bioinformatics tools improve these methods with greater statistical rigour and offer insight into the complex environmental context [31] .

Next-Generation Sequencing (NGS) technology has made it possible to conduct investigations on intricate microbial systems more successfully than in the past. However, data might be skewed, over- or underestimating bacterial abundance due to biases imposed by PCR-based sequencing technologies [34] . Primer efficiency, PCR amplification settings, sequencing platform, bioinformatics pipeline, and procedures for DNA extraction and sample handling can all induce biases into the results of 16S rRNA amplicon sequencing [35] . These internal biases are a major contributing factor to the difficulty in reproducing results in microbiome investigations, as demonstrated by the Microbiome Quality Control project (MBQC), a consortium of scientists working to standardise microbiome studies [36] .

One of the most promising areas of research on the gut-brain connection is the development of new probiotic strains and formulations that are specifically targeted to treat neurological and psychiatric disorders [37] . One recent meta-analysis of probiotic intervention in clinical depression found that probiotics are best used as an adjunct to antidepressants rather than as a stand-alone treatment, despite the fact that the majority of pre-clinical studies and some clinical studies have demonstrated the efficacy of probiotics as a stand-alone treatment in depressive disorders [38] . Probiotics could be used as a supplement to antidepressants to address certain depressive symptoms.

A different angle on the theoretical understanding of the dynamic interaction between the gut microbiota and the host’s genome within the microbiota-gut-brain axis (MGBA) is revealed by epigenetic mechanisms, which integrate environmental signals to modify gene expression, independent of changes in the actual DNA sequence. The host’s gene expression can change heritably through well-studied epigenetic mechanisms such as histone tail modifications, DNA methylation, and non-coding RNAs. Enzyme-mediated changes to DNA and histones can either enhance or decrease the expression of a gene [39] . One possible mechanism by which the gut microbiota modulates these epigenetic changes is through its metabolites (SCFAs; butyrate, acetate, and propionate), which can do so by directly inhibiting enzymes or by changing the availability of substrates necessary for enzymatic activity [40] .

This complex interplay between the gut microbiome and epigenetic machinery highlights the fascinating potential for microbial communities to shape not only our individual health but also the health of future generations. Trillions of commensal microbes, known as the microbiota, are constantly present in the gastrointestinal system and operate as environmental triggers that might influence a host’s health or illness. Microbial signals are incorporated not only through documented bacterial sensing mechanisms but also through epigenetic alterations that adjust the transcriptional programme of host cells without changing the underlying genetic code. Epigenetic modifications that are sensitive to the microbiota encompass adjustments made to DNA or histones, in addition to the control of non-coding RNAs. Although epigenetic pathways responsive to microbiota have been identified in peripheral tissues and local intestine cells, more investigation is needed to completely understand the intricate interplay between the microbiota and the host [41] .